---
title: Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation
  for progression-free and overall survival
date: '2022-05-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/35567637/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20220518212700&v=2.17.6
source: metablomics[MeSH Terms]
description: 'CONCLUSION: Metabolomic analysis of lung tumor core biopsies has the
  potential to differentiate patients into low- and high-risk groups based on OS and
  PFS events and ...'
---
CONCLUSION: Metabolomic analysis of lung tumor core biopsies has the potential to differentiate patients into low- and high-risk groups based on OS and PFS events and ...